$ONCO
Onconetix, Inc. Stock $onco

$onco Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000121390024032225 Filed on April 11, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue	$704.8K	$58.47K	$58.47K
YoY Change
Cost Of Revenue	$604.1K	$1.186M	$1.186M
YoY Change
Gross Profit	$100.7K	-$1.127M	-$1.127M
YoY Change
Gross Profit Margin	14.29%	-1927.76%	-1927.93%
Selling, General & Admin	$2.221M	$6.433M	$14.77M
YoY Change	2711.74%	215.3%	57.95%
% of Gross Profit	2205.48%
Research & Development	-$3.680K	-$198.9K	$1.949M
YoY Change	-100.43%	-116.5%	-52.8%
% of Gross Profit	-3.65%
Depreciation & Amortization	$201.3K	$43.94K	$43.94K
YoY Change		2288.04%	550.73%
% of Gross Profit	199.87%
Operating Expenses	$13.72M	$6.234M	$34.91M
YoY Change	106.26%	92.06%	158.93%
Operating Profit	-$13.62M	-$7.361M	-$36.03M
YoY Change	104.75%		167.29%
Interest Expense	-$609.3K	-$314.8K	$671.6K
YoY Change	-384.73%	-1222.72%	993.67%
% of Operating Profit
Other Income/Expense, Net	-$640.9K		$50.00K
YoY Change	197.17%		-18.58%
Pretax Income	-$14.26M	-$22.36M	-$37.42M
YoY Change	107.51%	594.96%	178.86%
Income Tax	$50.77K	-$12.59K	-$12.59K
% Of Pretax Income
Net Earnings	-$14.31M	-$22.35M	-$37.41M
YoY Change	108.39%	594.57%	178.76%
Net Earnings / Revenue	-2029.76%	-38226.22%	-63986.48%
Basic Earnings Per Share	-$0.64		-$2.19
Diluted Earnings Per Share	-$0.64	-$1.17	-$2.19
COMMON SHARES
Basic Shares Outstanding	22.33M shares	17.99M shares	17.11M shares
Diluted Shares Outstanding	22.20M shares		17.11M shares

Balance Sheet

Concept	2024 Q2	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$930.5K	$4.554M	$4.554M
YoY Change	-89.91%	-82.32%	-82.32%
Cash & Equivalents	$930.5K	$4.554M
Short-Term Investments
Other Short-Term Assets	$717.7K	$770.2K	$770.2K
YoY Change	4.01%	64.13%	64.13%
Inventory	$160.3K	$364.1K	$364.1K
Prepaid Expenses
Receivables	$171.3K	$149.7K	$149.7K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$2.035M	$5.838M	$5.838M
YoY Change	-82.15%	-77.77%	-77.77%
LONG-TERM ASSETS
Property, Plant & Equipment	$69.19K	$60.65K	$209.2K
YoY Change	390.01%	330.51%	1384.74%
Goodwill	$36.50M	$55.68M
YoY Change
Intangibles	$20.31M	$25.41M
YoY Change	13.43%
Long-Term Investments
YoY Change
Other Assets	$366.1K	$383.5K	$383.5K
YoY Change	-12.83%	893.11%	893.11%
Total Long-Term Assets	$57.43M	$81.68M	$81.68M
YoY Change	213.09%	154872.41%	154860.65%
TOTAL ASSETS
Total Short-Term Assets	$2.035M	$5.838M	$5.838M
Total Long-Term Assets	$57.43M	$81.68M	$81.68M
Total Assets	$59.46M	$87.52M	$87.52M
YoY Change	99.9%	232.64%	232.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.170M	$5.295M	$5.295M
YoY Change	52.63%	253.17%	253.17%
Accrued Expenses	$1.439M	$2.200M	$2.274M
YoY Change	1.34%	-8.69%	-5.6%
Deferred Revenue
YoY Change
Short-Term Debt	$14.99M	$9.618M	$9.618M
YoY Change	73.87%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$20.60M	$17.19M	$17.19M
YoY Change	69.8%	338.25%	338.25%
LONG-TERM LIABILITIES
Long-Term Debt	$111.3K	$118.9K	$118.9K
YoY Change	-97.55%
Other Long-Term Liabilities	$435.9K	$1.495M	$1.495M
YoY Change
Total Long-Term Liabilities	$547.1K	$1.613M	$1.613M
YoY Change	-87.95%
TOTAL LIABILITIES
Total Short-Term Liabilities	$20.60M	$17.19M	$17.19M
Total Long-Term Liabilities	$547.1K	$1.613M	$1.613M
Total Liabilities	$23.96M	$21.88M	$28.88M
YoY Change	43.7%	457.75%	636.38%
SHAREHOLDERS EQUITY
Retained Earnings	-$82.21M	-$56.79M
YoY Change	182.63%	193.07%
Common Stock	$228.00	$228.00
YoY Change	34.91%	45.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$625.8K	$625.8K
YoY Change	0.0%	10.41%
Treasury Stock Shares
Shareholders Equity	-$35.81M	-$5.602M	$58.63M
YoY Change
Total Liabilities & Shareholders Equity	$59.46M	$87.52M	$87.52M
YoY Change	99.9%	232.64%	232.64%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$14.31M	-$22.35M	-$37.41M
YoY Change	108.39%	594.57%	178.76%
Depreciation, Depletion And Amortization	$201.3K	$43.94K	$43.94K
YoY Change		2288.04%	550.73%
Cash From Operating Activities	-$3.200M	-$4.311M	-$13.58M
YoY Change	79.75%	53.9%	56.12%
INVESTING ACTIVITIES
Capital Expenditures	$17.70K	$4.820K	$3.300K
YoY Change	-99.71%		-64.66%
Acquisitions			-$1.057M
YoY Change
Other Investing Activities		$1.216M	-$2.514M
YoY Change
Cash From Investing Activities	-$17.70K	$1.211M	-$8.649M
YoY Change	-99.82%		92512.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-343.4K	-4.940K	$1.035M
YoY Change	63.53%	-99.15%	-96.82%
NET CHANGE
Cash From Operating Activities	-3.200M	-4.311M	-$13.58M
Cash From Investing Activities	-17.70K	1.211M	-$8.649M
Cash From Financing Activities	-343.4K	-4.940K	$1.035M
Net Change In Cash	-3.561M	-3.105M	-$21.20M
YoY Change	-70.4%	-8.25%	-188.98%
FREE CASH FLOW
Cash From Operating Activities	-$3.200M	-$4.311M	-$13.58M
Capital Expenditures	$17.70K	$4.820K	$3.300K
Free Cash Flow	-$3.217M	-$4.316M	-$13.58M
YoY Change	-59.07%	54.07%	55.99%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-41294
CY2023	dei	Entity Registrant Name EntityRegistrantName	Onconetix, Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	81-2262816
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	201 E. Fifth Street
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1900
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Cincinnati
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	OH
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	45202
CY2023	dei	City Area Code CityAreaCode	(513)
CY2023	dei	Local Phone Number LocalPhoneNumber	620-4101
CY2023	dei	Security12b Title Security12bTitle	Common stock, $0.00001 par value
CY2023	dei	Trading Symbol TradingSymbol	ONCO
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	13000000.0	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	22327701	shares
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	199
CY2023	dei	Auditor Name AuditorName	Mayer Hoffman McCann P.C.
CY2023	dei	Auditor Location AuditorLocation	Los Angeles, California
CY2023Q4	us-gaap	Cash Cash	4554335	usd
CY2022Q4	us-gaap	Cash Cash	25752659	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	149731	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	364052	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	770153	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	469232	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	5838271	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	26257741	usd
CY2023Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	17423	usd
CY2022Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	38617	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	60654	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14089	usd
CY2023Q4	us-gaap	Deferred Costs DeferredCosts	366113	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	148542	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	25410887	usd
CY2023Q4	us-gaap	Goodwill Goodwill	55676142	usd
CY2023Q4	us-gaap	Assets Assets	87518032	usd
CY2022Q4	us-gaap	Assets Assets	26310447	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5295114	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1499296	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2199867	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2409128	usd
CY2023Q4	bwv	Notes Payable Net Of Debt Discount NotesPayableNetOfDebtDiscount	381627	usd
CY2022Q4	bwv	Notes Payable Net Of Debt Discount NotesPayableNetOfDebtDiscount	381627	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	9618373	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	74252	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	2641	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	14021	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	17190247	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3922445	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	118857	usd
CY2023Q4	bwv	Subscription Agreement Liability Noncurrent SubscriptionAgreementLiabilityNoncurrent	864000	usd
CY2023Q4	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	556296	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	74290	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	3073781	usd
CY2023Q4	us-gaap	Liabilities Liabilities	21877471	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3922445	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	64236085	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22841975	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15724957	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22324576	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15265228	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	228	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	157	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	49428809	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	42331155	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	517399	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	459729	shares
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	625791	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	566810	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-56786194	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19376500	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2380920	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-5602028	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	22388002	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	7006504	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1404476	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	22388002	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	87518032	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26310447	usd
CY2023	us-gaap	Revenues Revenues	58465	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	1185630	usd
CY2023	us-gaap	Gross Profit GrossProfit	-1127165	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	14770678	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9351552	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1949406	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4129688	usd
CY2023	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	14687346	usd
CY2023	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	3500000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	34907430	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	13481240	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-36034595	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-13481240	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-490000	usd
CY2023	us-gaap	Interest Expense InterestExpense	671625	usd
CY2023	bwv	Change In Fair Value Of Subscription Agreement Liability ChangeInFairValueOfSubscriptionAgreementLiability	-134100	usd
CY2023	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-91967	usd
CY2022	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	61410	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1387692	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	61410	usd
CY2023	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-37422287	usd
CY2022	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-13419830	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-12593	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-37409694	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-13419830	usd
CY2022	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	96359	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-37409694	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13516189	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.19
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.1
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17111374	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12271449	shares
CY2023	us-gaap	Profit Loss ProfitLoss	-37409694	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-13419830	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-2374957	usd
CY2023	bwv	Change In Pension Benefit Obligation ChangeInPensionBenefitObligation	5963	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-35028774	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13419830	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1446577	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	17138840	usd
CY2022	bwv	Stock Issued During Period Value Ofssuance Of Common Stock And Warrants StockIssuedDuringPeriodValueOfssuanceOfCommonStockAndWarrants	6858328	usd
CY2022	bwv	Stock Issued During Period Value Issuanceof Common Stockand Warrantsin Private Placement StockIssuedDuringPeriodValueIssuanceofCommonStockandWarrantsinPrivatePlacement	8689316	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1655	usd
CY2023	us-gaap	Payments To Acquire Restricted Certificates Of Deposit PaymentsToAcquireRestrictedCertificatesOfDeposit	3500000	usd
CY2022	bwv	Exercise Of Prefunded Warrants ExerciseOfPrefundedWarrants	1436	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	263924	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1974566	usd
CY2022	bwv	Purchase Of Treasury Shares PurchaseOfTreasuryShares	566810	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-13419830	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	22388002	usd
CY2023	bwv	Issuance Of Common Stock From Exercise Of Preferred Investment Options IssuanceOfCommonStockFromExerciseOfPreferredInvestmentOptions	2272838	usd
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	129184	usd
CY2023	bwv	Stock Issued During Period Value Issuance Of Series A Preferred Stock StockIssuedDuringPeriodValueIssuanceOfSeriesAPreferredStock	3490000	usd
CY2023	bwv	Stock Issued During Period Value Issuance Of Common Stock And Series B Preferred Stock In Connection With Pmx Transaction StockIssuedDuringPeriodValueIssuanceOfCommonStockAndSeriesBPreferredStockInConnectionWithPMXTransaction	875484	usd
CY2023	bwv	Stock Issued During Period Value Assumption Of Stockbased Compensation Plan Awards In Connection With Pmx Transaction StockIssuedDuringPeriodValueAssumptionOfStockbasedCompensationPlanAwardsInConnectionWithPMXTransaction	7006504	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	459	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	329760	usd
CY2023	bwv	Purchase Of Treasury Shares PurchaseOfTreasuryShares	58981	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-2374957	usd
CY2023	bwv	Stock Issued During Period Value Of Changes In Pension Benefit Obligation StockIssuedDuringPeriodValueOfChangesInPensionBenefitObligation	5963	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-37409694	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1404476	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-37409694	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-13419830	usd
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	14687346	usd
CY2023	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	3500000	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	729900	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	671373	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-490000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	329760	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1974566	usd
CY2023	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-267019	usd
CY2023	bwv	Gain Loss On Related Party Receivable GainLossOnRelatedPartyReceivable	265648	usd
CY2023	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-159000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-12593	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	1152369	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	43937	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6752	usd
CY2023	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	-91967	usd
CY2022	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	61410	usd
CY2023	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	134100	usd
CY2023	us-gaap	Pension Expense PensionExpense	13875	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	263924	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	62286	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	315828	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	412601	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	234681	usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	16883	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	38617	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3372648	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1093913	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-942075	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1739849	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13581018	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8675534	usd
CY2023	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	79771	usd
CY2022	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	79771	usd
CY2023	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	6079771	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-1056578	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	51744	usd
CY2023	bwv	Receivable From Related Parties1 ReceivableFromRelatedParties1	70798	usd
CY2022	bwv	Receivable From Related Parties1 ReceivableFromRelatedParties1	23326	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3300	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9339	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8649035	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-32665	usd
CY2023	bwv	Payments For Purchase Of Treasury Shares PaymentsForPurchaseOfTreasuryShares	58981	usd
CY2022	bwv	Payments For Purchase Of Treasury Shares PaymentsForPurchaseOfTreasuryShares	566810	usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	205093	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1000000	usd
CY2023	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	2298675	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	459	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1655	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	18400000	usd
CY2022	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering	926972	usd
CY2022	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	16468123	usd
CY2022	us-gaap	Payments For Repurchase Of Private Placement PaymentsForRepurchaseOfPrivatePlacement	845048	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1436	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1035060	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	32532384	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-3331	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-21198324	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	23824185	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25752659	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1928474	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4554335	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25752659	usd
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Inventory Acquired1 NoncashOrPartNoncashAcquisitionInventoryAcquired1	12947000	usd
CY2023	bwv	Effect Of Business Combination EffectOfBusinessCombination	64054991	usd
CY2023	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	3490000	usd
CY2023	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	2613011	usd
CY2022	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	860204	usd
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	150000	usd
CY2023	bwv	Recognition Of Contingent Warrant Liability Upon Issuance Of Common Stock In Private Placement RecognitionOfContingentWarrantLiabilityUponIssuanceOfCommonStockInPrivatePlacement	25837	usd
CY2022	bwv	Recognition Of Contingent Warrant Liability Upon Issuance Of Common Stock In Private Placement RecognitionOfContingentWarrantLiabilityUponIssuanceOfCommonStockInPrivatePlacement	75431	usd
CY2023	bwv	Warrants Issued For Settlement Of Contingent Warrants WarrantsIssuedForSettlementOfContingentWarrants	129184	usd
CY2023	bwv	Deferred Offering Costs Previously Prepaid DeferredOfferingCostsPreviouslyPrepaid	-11020	usd
CY2023	bwv	Exerciseofprefundedwarrants Exerciseofprefundedwarrants	7	usd
CY2022	bwv	Exerciseofprefundedwarrants Exerciseofprefundedwarrants	6	usd
CY2023	bwv	Issuance Of Restricted Stock IssuanceOfRestrictedStock	5	usd
CY2023	bwv	Restricted Stock Forfeitures RestrictedStockForfeitures	-3	usd
CY2022	bwv	Payment Of Accrued Bonus Through Related Party Receivable PaymentOfAccruedBonusThroughRelatedPartyReceivable	140000	usd
CY2022	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	45	usd
CY2023	us-gaap	Reclassifications Of Temporary To Permanent Equity ReclassificationsOfTemporaryToPermanentEquity	23000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	17100000	usd
CY2022Q1	us-gaap	Convertible Preferred Stock Shares Reserved For Future Issuance ConvertiblePreferredStockSharesReservedForFutureIssuance	5626365	shares
CY2023	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	2300000	usd
CY2023Q4	us-gaap	Cash Cash	4600000	usd
CY2023Q4	bwv	Working Capital Deficit WorkingCapitalDeficit	11400000	usd
CY2023Q4	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	-56800000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. The most significant estimates in the Company’s consolidated financial statements relate to accounting for acquisitions, valuation of inventory, the useful life of the amortizable intangible assets, estimates of future cash flows used to evaluate impairment of intangible assets, accrued research and development expenses, assumptions related to the pension benefit obligation, stock-based compensation, the valuation of preferred stock, and the valuation allowance of deferred tax assets. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results may differ materially and adversely from these estimates. To the extent there are material differences between the estimates and actual results, the Company’s future results of operations will be affected.</p>
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Concentration of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in financial institutions, which, at times, exceed the Federal Depository Insurance Coverage limit for those maintained in the United States and exceed the Swiss Financial Market Supervisory Authority for those maintained in Switzerland. As of December 31, 2023 and 2022, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2023	us-gaap	Revenues Revenues	58465	usd
CY2023Q4	us-gaap	Noncurrent Assets NoncurrentAssets	209196	usd
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	14089	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1200000	usd
CY2023	us-gaap	Depreciation Depreciation	7000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	14700000	usd
CY2023	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	267000	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	2641	usd
CY2023Q4	bwv	Subscription Agreement Liability Noncurrent SubscriptionAgreementLiabilityNoncurrent	864000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	866641	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	14021	usd
CY2023	us-gaap	Recognition Of Deferred Revenue RecognitionOfDeferredRevenue	59000	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	87000	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	150000	usd
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	15771006	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6656928	shares
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	139208	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	194805	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	30039	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	364052	usd
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	122004	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	148789	usd
CY2023Q4	us-gaap	Prepaid Rent PrepaidRent	312551	usd
CY2023Q4	bwv	Prepaids Research And Development PrepaidsResearchAndDevelopment	89195	usd
CY2022Q4	bwv	Prepaids Research And Development PrepaidsResearchAndDevelopment	231981	usd
CY2023Q4	bwv	Prepaid Professional Fees PrepaidProfessionalFees	70708	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	175695	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	88462	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	770153	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	469232	usd
CY2023Q4	bwv	Finite Lived Intangible Asset Cost FiniteLivedIntangibleAssetCost	39356771	usd
CY2023	bwv	Impairment Of Intangible Asset Excluding Goodwill ImpairmentOfIntangibleAssetExcludingGoodwill	-14610128	usd
CY2023	us-gaap	Finite Lived Intangible Assets Foreign Currency Translation Gain Loss FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss	701056	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	25447699	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	36812	usd
CY2023	bwv	Finite Lived Intangible Assets Accumulated Amortization Effect Of Currency Translation FiniteLivedIntangibleAssetsAccumulatedAmortizationEffectOfCurrencyTranslation	-36812	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	25410887	usd
CY2023Q4	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P15Y
CY2023	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	31000	usd
CY2023	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	6000	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	14700000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1012870	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1326837	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1326837	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1326837	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1326837	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	9777930	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	16098148	usd
CY2023	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P13Y6M
CY2023Q4	us-gaap	Indefinite Lived Trade Names IndefiniteLivedTradeNames	9300000	usd
CY2023	us-gaap	Goodwill Transfers GoodwillTransfers	53914055	usd
CY2023	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	1762087	usd
CY2023Q4	us-gaap	Goodwill Goodwill	55676142	usd
CY2023Q4	bwv	Accrued Research And Development Current AccruedResearchAndDevelopmentCurrent	616707	usd
CY2022Q4	bwv	Accrued Research And Development Current AccruedResearchAndDevelopmentCurrent	847747	usd
CY2023Q4	us-gaap	Accrued Utilities Current And Noncurrent AccruedUtilitiesCurrentAndNoncurrent	487579	usd
CY2022Q4	us-gaap	Accrued Utilities Current And Noncurrent AccruedUtilitiesCurrentAndNoncurrent	1132859	usd
CY2023Q4	bwv	Accrued Deferred Offering Costs AccruedDeferredOfferingCosts	125000	usd
CY2022Q4	bwv	Accrued Deferred Offering Costs AccruedDeferredOfferingCosts	125000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	550415	usd
CY2023Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	93787	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	265849	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	125922	usd
CY2023Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	60530	usd
CY2022Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	177600	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2199867	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2409128	usd
CY2023Q2	bwv	Royalty Sales Percentage RoyaltySalesPercentage	0.06	pure
CY2023Q2	bwv	Sales Payments Amount SalesPaymentsAmount	22500000	usd
CY2023Q4	bwv	Aggregate Purchase Shares AggregatePurchaseShares	5709935	shares
CY2023	bwv	Business Transaction Yeare BusinessTransactionYeare	P5Y
CY2023	bwv	Inventory Fair Value InventoryFairValue	300000	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	14700000	usd
CY2023	bwv	Impairment Rate ImpairmentRate	1	pure
CY2023	us-gaap	Business Acquisition Pro Forma Information Description BusinessAcquisitionProFormaInformationDescription	(i) $3.5 million in cash at signing of the WraSer APA; (ii) $4.5 million in cash on the later of (x) 90 days after the signing of the WraSer APA or (y) the date that all closing conditions under the WraSer APA are met or otherwise waived (the “WraSer Closing Date”); (iii) 1.0 million shares of the Company’s common stock (the “Closing Shares”) issuable on the WraSer Closing Date, and (iv) $500,000 in cash one year from the WraSer Closing Date.
CY2023Q4	bwv	Initial Payment Amount InitialPaymentAmount	3500000	usd
CY2023	bwv	Payments Payments	3500000	usd
CY2023Q4	us-gaap	Deposits Deposits	3500000	usd
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	1100000	usd
CY2023Q3	us-gaap	Business Combination Separately Recognized Transactions Additional Disclosures Acquisition Costs BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts	500000	usd
CY2023	us-gaap	Payments For Fees PaymentsForFees	3500000	usd
CY2023Q4	bwv	Voting Interest Percentage VotingInterestPercentage	1	pure
CY2023Q4	bwv	Stock Issued During Period Shares Issuance Of Common Stock And Series B Preferred Stock In Connection With Pmx Transaction StockIssuedDuringPeriodSharesIssuanceOfCommonStockAndSeriesBPreferredStockInConnectionWithPMXTransaction	3675414	shares
CY2023	bwv	Royalty Rate RoyaltyRate	0.06	pure
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	1500000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	669000	usd
CY2023	bwv	Royalty Net Sales Percentage RoyaltyNetSalesPercentage	0.04	pure
CY2023Q4	us-gaap	Product Liability Contingency Accrual Discount Rate ProductLiabilityContingencyAccrualDiscountRate	0.02	pure
CY2023	us-gaap	Development Costs DevelopmentCosts	500000	usd
CY2018	bwv	Royalty Rates RoyaltyRates	0.25	pure
CY2018	bwv	Aggregate Royalties Amount AggregateRoyaltiesAmount	51250000	usd
CY2023	us-gaap	Proceeds From License Fees Received ProceedsFromLicenseFeesReceived	100000	usd
CY2023Q3	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	800000	usd
CY2023Q3	us-gaap	Long Term Debt Maturity Date LongTermDebtMaturityDate	2025-07-14
CY2023	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	3100000	usd
CY2023Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	1800000	usd
CY2023	bwv	Payable Average Discount Rate Percentage PayableAverageDiscountRatePercentage	0.082	pure
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	700000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	400000	usd
CY2023Q3	us-gaap	Notes Payable NotesPayable	4000000	usd
CY2023Q3	bwv	Debt Instrument Due Date DebtInstrumentDueDate	2023-09-30
CY2023Q3	bwv	Cash Payment To The Seller CashPaymentToTheSeller	1000000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	490000	usd
CY2023	bwv	Debt Instrument Due Term DebtInstrumentDueTerm	P2024Y
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	119000	usd
CY2023Q4	bwv	Sale Of Units SaleOfUnits	20000000	shares
CY2023Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.25
CY2023Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.25
CY2023	us-gaap	Servicing Liability At Fair Value Additions ServicingLiabilityAtFairValueAdditions	800000	usd
CY2023Q4	us-gaap	Servicing Liability At Fair Value Amount ServicingLiabilityAtFairValueAmount	900000	usd
CY2023	us-gaap	Product Liability Contingency Third Party Recovery Percentage ProductLiabilityContingencyThirdPartyRecoveryPercentage	0.55	pure
CY2023Q3	bwv	Shares Of Common Stock Issued SharesOfCommonStockIssued	2486214	shares
CY2023Q3	us-gaap	Stock Option Exercise Price Decrease StockOptionExercisePriceDecrease	1.09
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Other Notes Payable OtherNotesPayable	3000000	usd
CY2023Q4	us-gaap	Preferred Stock Convertible Conversion Price PreferredStockConvertibleConversionPrice	0.5254
CY2023Q4	us-gaap	Preferred Stock Convertible Shares Issuable PreferredStockConvertibleSharesIssuable	5709935	shares
CY2023Q4	us-gaap	Preferred Stock Convertible Shares Issuable PreferredStockConvertibleSharesIssuable	2696729	shares
CY2023Q4	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	100	shares
CY2023	bwv	Percentage Of Issued Of Common Stock PercentageOfIssuedOfCommonStock	0.20	pure
CY2023	bwv	Percentage Of Outstanding Of Common Stock PercentageOfOutstandingOfCommonStock	0.20	pure
CY2022Q4	us-gaap	Preferred Stock Convertible Conversion Price PreferredStockConvertibleConversionPrice	1.52
CY2022	bwv	Percentage Of Cumulative Dividends PercentageOfCumulativeDividends	0.08	pure
CY2022	bwv	Netting Proceeds NettingProceeds	50000000	usd
CY2022	bwv	Percentage Of Original Issue Price PercentageOfOriginalIssuePrice	3	pure
CY2022Q1	us-gaap	Cumulative Dividends CumulativeDividends	1586162	usd
CY2022Q1	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	1.38
CY2022Q1	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	5626365	shares
CY2023Q4	us-gaap	Common Unit Issued CommonUnitIssued	3675414	shares
CY2022Q1	us-gaap	Stock Issued1 StockIssued1	2222222	usd
CY2022Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	9
CY2022Q1	bwv	Percentage Of Underwriting Discount PercentageOfUnderwritingDiscount	0.08	pure
CY2022Q1	us-gaap	Other Ownership Interests Offering Costs OtherOwnershipInterestsOfferingCosts	17100000	usd
CY2023Q4	us-gaap	Class Of Warrant Or Right Unissued ClassOfWarrantOrRightUnissued	111111	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	10.35
CY2022Q4	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	93466	shares
CY2022Q4	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	10000	usd
CY2022Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	254000	usd
CY2023Q4	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	4500000	shares
CY2022Q2	us-gaap	Preferred Stock Convertible Conversion Price PreferredStockConvertibleConversionPrice	6.775
CY2022Q2	bwv	Cancelled Preferred Investment Options Shares CancelledPreferredInvestmentOptionsShares	1180812	shares
CY2022Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.001
CY2022Q3	bwv	Cancelled Preferred Investment Options Shares CancelledPreferredInvestmentOptionsShares	1289148	shares
CY2023	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	39000	usd
CY2023Q1	bwv	Fixed Commission Rate FixedCommissionRate	0.03	pure
CY2023Q3	bwv	Aggregate Net Proceeds AggregateNetProceeds	2300000	usd
CY2023Q4	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	911214	shares
CY2023	us-gaap	Legal Fees LegalFees	50000	usd
CY2023	us-gaap	Other General Expense OtherGeneralExpense	35000	usd
CY2023	bwv	Aggregate Purchase Shares AggregatePurchaseShares	149173	shares
CY2023	bwv	Percentage Of Common Stock Shares PercentageOfCommonStockShares	0.06	pure
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	298346	shares
CY2023	bwv	Aggregate Net Proceeds AggregateNetProceeds	2300000	usd
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	149173	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.178	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0424	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	70849	shares
CY2023Q4	us-gaap	Share Price SharePrice	0.2
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	298346	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.41
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.4
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	700000	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	2100000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	709768	shares
CY2023Q4	bwv	Exercise Price ExercisePrice	0.4305
CY2023Q4	bwv	Grant Date Fair Value Of Stock Option GrantDateFairValueOfStockOption	200000	usd
CY2023	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	100000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	100000	shares
CY2022	bwv	Grant Date Fair Value Of Stock Option GrantDateFairValueOfStockOption	1800000	usd
CY2023Q2	us-gaap	Restricted Stock Shares Issued Net Of Shares For Tax Withholdings RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings	150000	shares
CY2023Q2	us-gaap	Restricted Stock Shares Issued Net Of Shares For Tax Withholdings RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings	25440	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	512940	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.01
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	250110	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	1.02
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	6250	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	1.03
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	256580	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	1.03
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.46
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	3.17
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	7400000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	7100000	usd
CY2023Q4	us-gaap	Shares Held In Employee Stock Option Plan Allocated SharesHeldInEmployeeStockOptionPlanAllocated	47990	shares
CY2023	us-gaap	Stock Option Exercise Price Decrease StockOptionExercisePriceDecrease	3.94
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P4Y6M10D
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	329760	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1974566	usd
CY2022	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	100000	usd
CY2022Q2	us-gaap	Short Term Lease Payments ShortTermLeasePayments	14000	usd
CY2023	us-gaap	Payments For Rent PaymentsForRent	51000	usd
CY2023	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	4000	usd
CY2022	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	12000	usd
CY2022Q4	us-gaap	Legal Fees LegalFees	50000	usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	111111	shares
CY2022Q4	us-gaap	Shares Issued SharesIssued	200000	shares
CY2022Q4	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	264000	usd
CY2022	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	1300000	usd
CY2023	bwv	Percentage Of Subscription PercentageOfSubscription	0.02	pure
CY2023	bwv	Aggregate Payments AggregatePayments	59.75	usd
CY2022Q1	us-gaap	Liabilities Subject To Compromise Early Contract Termination Fees LiabilitiesSubjectToCompromiseEarlyContractTerminationFees	300000	usd
CY2023	us-gaap	Labor And Related Expense LaborAndRelatedExpense	209000	usd
CY2023	us-gaap	Dividends Paidinkind DividendsPaidinkind	159000	usd
CY2023	us-gaap	Other Expenses OtherExpenses	50000	usd
CY2023	bwv	Subscription Agreement Pmx Investor Percentage SubscriptionAgreementPMXInvestorPercentage	0.05	pure
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-37106599	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-13419830	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-315688	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-37422287	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13419830	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	10214760	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2986738	usd
CY2023Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	3349919	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	885176	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	1171320	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	690760	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	308552	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	854896	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	150099	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	186573	usd
CY2023Q4	bwv	License Agreement LicenseAgreement	49157	usd
CY2022Q4	bwv	License Agreement LicenseAgreement	82626	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	520207	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	65886	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	17001118	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	4515551	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	15697701	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4512546	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1303417	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3005	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	4345449	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	2560	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	3005	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	29189	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	4377198	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3005	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	3073781	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	11200000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	3200000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-7858680	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2818164	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-1192605	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-501277	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	16477	usd
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	315927	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	196025	usd
CY2023	bwv	Income Tax Reconciliation Nondeductible Expense Derivative Liability IncomeTaxReconciliationNondeductibleExpenseDerivativeLiability	181440	usd
CY2023	bwv	Income Tax Reconciliation Nondeductible Expense Officers Compensation IncomeTaxReconciliationNondeductibleExpenseOfficersCompensation	-126337	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	164073	usd
CY2023	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	55486	usd
CY2022	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	194705	usd
CY2023	bwv	Effective Income Tax Rate Reconciliation Nondeductible Expense State Rate Adjustment EffectiveIncomeTaxRateReconciliationNondeductibleExpenseStateRateAdjustment	-23135	usd
CY2022	bwv	Effective Income Tax Rate Reconciliation Nondeductible Expense State Rate Adjustment EffectiveIncomeTaxRateReconciliationNondeductibleExpenseStateRateAdjustment	19600	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	60599	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-37260	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	8214614	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	3158873	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-12593	usd
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.50	pure
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	17010	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	11517	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	5493	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	17010	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	17010	usd
CY2023	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	17010	usd
CY2022	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	17010	usd
CY2022Q1	us-gaap	Defined Contribution Plan Employers Matching Contribution Annual Vesting Percentage DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage	1	pure
CY2023	bwv	Gross Pay Percentage GrossPayPercentage	0.03	pure
CY2023	bwv	Debt Securities And Cash DebtSecuritiesAndCash	0.38	pure
CY2023	bwv	Equity Securities Rate EquitySecuritiesRate	0.26	pure
CY2023	bwv	Alternative Investments Rate AlternativeInvestmentsRate	0.12	pure
CY2023	bwv	Real Estate Investments Rate RealEstateInvestmentsRate	0.24	pure
CY2023Q4	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate	0.0145	pure
CY2023Q4	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Weighted Average Interest Crediting Rate DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate	0.0145	pure
CY2023Q4	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease	0.03	pure
CY2023Q4	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	4278	usd
CY2023Q4	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	1943	usd
CY2023Q4	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	1581	usd
CY2023Q4	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	1534	usd
CY2023Q4	us-gaap	Defined Benefit Plan Recognized Net Gain Loss Due To Settlements And Curtailments1 DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1	1157	usd
CY2023Q4	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	1949	usd
CY2023	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent	7277	usd
CY2023	bwv	Amortization Of Net Gain AmortizationOfNetGain	1534	usd
CY2023	bwv	Effect Of Settlement EffectOfSettlement	1157	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4005	usd
CY2023	us-gaap	Regulated And Unregulated Operating Revenue RegulatedAndUnregulatedOperatingRevenue	5963	usd
CY2023Q4	us-gaap	Defined Benefit Plan Pension Plan With Projected Benefit Obligation In Excess Of Plan Assets Projected Benefit Obligation DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation	2299970	usd
CY2023Q4	us-gaap	Defined Benefit Plan Pension Plans With Accumulated Benefit Obligations In Excess Of Plan Assets Aggregate Fair Value Of Plan Assets DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets	1743674	usd
CY2023Q4	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	556296	usd
CY2022	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill		usd
CY2022	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges		usd
CY2022	us-gaap	Interest Expense InterestExpense		usd
CY2022	bwv	Change In Fair Value Of Subscription Agreement Liability ChangeInFairValueOfSubscriptionAgreementLiability		usd
CY2023	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		usd
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12271449	shares
CY2023Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Two DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo	95100	usd
CY2023Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Three DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree	95100	usd
CY2023Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Four DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour	95100	usd
CY2023Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Five DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive	95100	usd
CY2023Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Five Fiscal Years Thereafter DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter	553900	usd
CY2023Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Current And Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent	934300	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		usd
CY2022Q4	us-gaap	Inventory Net InventoryNet		usd
CY2022Q4	us-gaap	Deferred Costs DeferredCosts		usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill		usd
CY2022Q4	us-gaap	Goodwill Goodwill		usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent		usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent		usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2022Q4	bwv	Subscription Agreement Liability Noncurrent SubscriptionAgreementLiabilityNoncurrent		usd
CY2022Q4	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent		usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax		usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest		usd
CY2022	us-gaap	Revenues Revenues		usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2022	us-gaap	Gross Profit GrossProfit		usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax		usd
CY2022	bwv	Change In Pension Benefit Obligation ChangeInPensionBenefitObligation		usd
CY2022	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges		usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges		usd
CY2022	bwv	Gain Loss On Related Party Receivable GainLossOnRelatedPartyReceivable		usd
CY2022	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown		usd
CY2022	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices		usd
CY2022	us-gaap	Pension Expense PensionExpense		usd
CY2023	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
CY2022	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets		usd
CY2022	us-gaap	Payments To Acquire Restricted Certificates Of Deposit PaymentsToAcquireRestrictedCertificatesOfDeposit		usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2022	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock		usd
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2023	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering		usd
CY2023	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants		usd
CY2023	us-gaap	Payments For Repurchase Of Private Placement PaymentsForRepurchaseOfPrivatePlacement		usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
CY2022	bwv	Effect Of Business Combination EffectOfBusinessCombination		usd
CY2022	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1		usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1		usd
CY2022	bwv	Warrants Issued For Settlement Of Contingent Warrants WarrantsIssuedForSettlementOfContingentWarrants		usd
CY2022	bwv	Deferred Offering Costs Previously Prepaid DeferredOfferingCostsPreviouslyPrepaid		usd
CY2022	bwv	Issuance Of Restricted Stock IssuanceOfRestrictedStock		usd
CY2022	bwv	Restricted Stock Forfeitures RestrictedStockForfeitures		usd
CY2023	bwv	Payment Of Accrued Bonus Through Related Party Receivable PaymentOfAccruedBonusThroughRelatedPartyReceivable		usd
CY2023	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1		usd
CY2022	us-gaap	Revenues Revenues		usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials		usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess		usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods		usd
CY2022Q4	us-gaap	Inventory Net InventoryNet		usd
CY2022Q4	us-gaap	Prepaid Rent PrepaidRent		usd
CY2022Q4	bwv	Prepaid Professional Fees PrepaidProfessionalFees		usd
CY2022Q4	us-gaap	Goodwill Goodwill		usd
CY2022Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent		usd
CY2022Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber		shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign		usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch		usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther		usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets		usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther		usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities		usd
CY2023	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch		usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential		usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost		usd
CY2022	bwv	Income Tax Reconciliation Nondeductible Expense Derivative Liability IncomeTaxReconciliationNondeductibleExpenseDerivativeLiability		usd
CY2022	bwv	Income Tax Reconciliation Nondeductible Expense Officers Compensation IncomeTaxReconciliationNondeductibleExpenseOfficersCompensation		usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits		usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions		usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions		usd
CY2023Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Next Twelve Months DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths		usd
CY2023	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost Credit Excluding Service Cost Statement Of Income Or Comprehensive Income Extensible List DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList	http://fasb.org/us-gaap/2023#DefinedBenefitPensionPlanLiabilitiesNoncurrent
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001782107

Files In Submission

Name	View Source	Status
0001213900-24-032225-index-headers.html	Edgar Link	pending
0001213900-24-032225-index.html	Edgar Link	pending
0001213900-24-032225.txt	Edgar Link	pending
0001213900-24-032225-xbrl.zip	Edgar Link	pending
bwv-20231231.xsd	Edgar Link	pending
bwv-20231231_def.xml	Edgar Link	unprocessable
bwv-20231231_lab.xml	Edgar Link	unprocessable
ea0201701-10k_onconetix.htm	Edgar Link	pending
ea020170101ex-19_onconetix.htm	Edgar Link	pending
ea020170101ex-21_onconetix.htm	Edgar Link	pending
ea020170101ex10-21_onconetix.htm	Edgar Link	pending
ea020170101ex10-22_onconetix.htm	Edgar Link	pending
ea020170101ex10-23_onconetix.htm	Edgar Link	pending
ea020170101ex10-24_onconetix.htm	Edgar Link	pending
ea020170101ex10-25_onconetix.htm	Edgar Link	pending
ea020170101ex10-26_onconetix.htm	Edgar Link	pending
ea020170101ex10-55_onconetix.htm	Edgar Link	pending
ea020170101ex23-1_onconetix.htm	Edgar Link	pending
ea020170101ex23-2_onconetix.htm	Edgar Link	pending
ea020170101ex31-1_onconetix.htm	Edgar Link	pending
ea020170101ex31-2_onconetix.htm	Edgar Link	pending
ea020170101ex32-1_onconetix.htm	Edgar Link	pending
ea020170101ex32-2_onconetix.htm	Edgar Link	pending
ea020170101ex4-2_onconetix.htm	Edgar Link	pending
ea020170101ex97_onconetix.htm	Edgar Link	pending
ex19_001.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ea0201701-10k_onconetix_htm.xml	Edgar Link	completed
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
bwv-20231231_cal.xml	Edgar Link	unprocessable
bwv-20231231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ONCO
Onconetix, Inc. Stock $onco

2024 Q2 Form 10-K Financial Statement

#000121390024032225 Filed on April 11, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ONCO Onconetix, Inc. Stock $onco

2024 Q2 Form 10-K Financial Statement

#000121390024032225 Filed on April 11, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ONCO
Onconetix, Inc. Stock $onco